Strategic Multimodal Non-Invasive Assessment of Cardiac Performance in Patients with Heart Failure

ESC Heart FailPublished Prospective observational study

Authors' conclusion

The combination of NT-proBNP and Echo-LVFP could be used to predict adverse outcomes in patients with HF of various stages. Left atrial mechanics and exercise capacity are incremental to prognostication.

Study context

Population
Consecutive hospitalized stage A-C heart failure (HF) patients evaluated with NT-proBNP, echocardiography incl. 2D speckle tracking, and cardiopulmonary exercise testinganalysed
Participants
224 participants
Exposure
Left ventricular filling pressure (LVFP) groups by NT-proBNP and echocardiographic LVFP grading
  • Group 1n = 123reference
  • Group 2n = 56
  • Group 3n = 45
Outcome
Adverse outcome: composite of CV death, non-fatal ACS, acute stroke, or HF-related hospitalization
Follow-up
18.6 ± 9.8 months
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

Event-free survival

Event-free survival in Group 2 better than Group 3 but worse than Group 1

log-rank P < 0.001

Observational data: associations, not effects.

Further findings

Predictors of adverse outcome

Mechanical left atrial dysfunction (peak longitudinal strain <28%), adjusted HR
5.69 (95% CI 1.06-4.48)
Limited exercise capacity (peak VO2 per +5 mL/kg/min), adjusted HR
0.63 (95% CI 0.46-0.87)
Serial addition of peak VO2 and left atrial strain incrementally enhanced predictive power of LVFP-based risk stratification
  • HR 5.69 is printed outside its CI 1.06-4.48, as printed

Original publication

Strategic Multimodal Non-Invasive Assessment of Cardiac Performance in Patients with Heart Failure. ESC Heart Fail. Published 13 June 2023. doi:10.1002/ehf2.14425

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.